ArticleInternational journal of molecular sciences2022

FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells.

Kenly Wuputra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.